Vanda Pharmaceuticals (VNDA) Stock Chart & Stock Price History $4.74 +0.01 (+0.21%) (As of 01:31 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Vanda Pharmaceuticals Stock Price Performance 5 Day Performance+1.74%1 Month Performance-5.82%3 Month Performance-5.25%6 Month Performance-26.03%Year-To-Date Performance+11.14%1 Year Performance+21.50% Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address This drone stock is setting up to transform medical supply delivery (Ad)Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.Click here to see how a new partnership could catapult this drone suppliers' growth VNDA Stock Chart for Wednesday, December, 18, 2024 VNDA Chart by TradingView Vanda Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$4.63$4.73+2.16%$4.75$4.60519,205 shs$275.80 million12/16/2024$4.61$4.63+0.43%$4.69$4.57403,071 shs$269.97 million12/13/2024$4.62$4.61-0.22%$4.62$4.51461,058 shs$268.81 million12/12/2024$4.67$4.62-1.07%$4.72$4.57633,925 shs$269.39 million12/11/2024$4.60$4.67+1.52%$4.79$4.451.78 million shs$272.30 million12/10/2024$4.82$4.60-4.56%$4.84$4.551.71 million shs$268.23 million Get the Latest News and Ratings for VNDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$4.84$4.82-0.41%$4.95$4.81616,584 shs$281.05 million12/06/2024$4.78$4.84+1.26%$4.87$4.74659,776 shs$282.21 million12/05/2024$4.84$4.78-1.24%$4.92$4.75538,065 shs$278.72 million12/04/2024$4.91$4.84-1.43%$4.91$4.76749,924 shs$282.22 million12/03/2024$5.04$4.91-2.58%$5.04$4.87670,994 shs$286.30 million12/02/2024$5.15$5.04-2.14%$5.15$5.03310,353 shs$293.87 million11/29/2024$5.19$5.15-0.77%$5.25$5.08264,858 shs$300.29 million11/28/2024$5.19$5.19$5.42$5.01833,924 shs$302.63 million11/27/2024$4.98$5.19+4.22%$5.42$5.01833,825 shs$302.63 million11/26/2024$5.05$4.98-1.39%$5.04$4.88529,282 shs$290.38 million11/25/2024$5.09$5.05-0.79%$5.21$5.04483,877 shs$294.46 million11/22/2024$4.94$5.09+3.04%$5.16$4.90587,658 shs$296.80 million11/21/2024$4.90$4.94+0.82%$4.94$4.83344,460 shs$288.05 million11/20/2024$4.92$4.90-0.41%$4.92$4.82396,102 shs$285.72 million11/19/2024$4.98$4.92-1.20%$4.96$4.84434,511 shs$286.89 million11/18/2024$5.00$4.98-0.40%$5.07$4.86609,914 shs$290.38 million Related Companies OPKO Health Stock Chart Ironwood Pharmaceuticals Stock Chart Sangamo Therapeutics Stock Chart Emergent BioSolutions Stock Chart Codexis Stock Chart Rigel Pharmaceuticals Stock Chart XOMA Stock Chart Verastem Stock Chart Lexicon Pharmaceuticals Stock Chart Achieve Life Sciences Stock Chart Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VNDA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
